Charles Schwab Investment Management Inc Concert Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $66,979 - $112,939	15,686 New	15,686 $106,000
Q2 2022 Aug 15, 2022	SELL	$2.8 - $6.36 $66,306 - $150,611	-23,681 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.73 - $3.94 $64,649 - $93,303	23,681 New	23,681 $80,000
Q3 2021 Nov 16, 2021	SELL	$3.17 - $4.15 $32,831 - $42,981	-10,357 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $245,468 - $341,181	-65,111 Reduced 86.28%	10,357 $44,000
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $17,010 - $45,745	3,500 Added 4.86%	75,468 $377,000
Q4 2020 Feb 16, 2021	BUY	$9.48 - $12.84 $20,315 - $27,516	2,143 Added 3.07%	71,968 $910,000
Q3 2020 Nov 13, 2020	SELL	$8.67 - $10.82 $18,839 - $23,511	-2,173 Reduced 3.02%	69,825 $686,000
Q2 2020 Aug 14, 2020	BUY	$7.8 - $11.52 $38,009 - $56,136	4,873 Added 7.26%	71,998 $717,000
Q1 2020 May 15, 2020	BUY	$5.98 - $13.09 $94,621 - $207,123	15,823 Added 30.84%	67,125 $594,000
Q4 2019 Feb 07, 2020	BUY	$5.71 - $9.22 $14,132 - $22,819	2,475 Added 5.07%	51,302 $474,000
Q2 2019 Aug 09, 2019	BUY	$9.44 - $13.12 $25,091 - $34,872	2,658 Added 5.76%	48,827 $586,000
Q1 2019 May 14, 2019	BUY	$12.07 - $17.54 $18,455 - $26,818	1,529 Added 3.43%	46,169 $558,000
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $568,653 - $817,344	-50,547 Reduced 53.1%	44,640 $561,000
Q2 2018 Aug 08, 2018	BUY	$16.83 - $21.66 $126,224 - $162,450	7,500 Added 8.55%	95,187 $1.6 Million
Q1 2018 May 07, 2018	BUY	$19.24 - $28.03 $982,509 - $1.43 Million	51,066 Added 139.44%	87,687 $2.01 Million
Q4 2017 Jan 17, 2018	BUY	$13.96 - $29.05 $62,806 - $130,695	4,499 Added 14.01%	36,621 $948,000
Q3 2017 Nov 13, 2017	BUY	$13.91 - $15.31 $446,817 - $491,787	32,122	32,122 $474,000

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account